|
humans |
29 |
|
periodontitis |
26 |
|
adult |
24 |
|
middle aged |
23 |
|
oral health |
21 |
|
aged |
20 |
|
periodontal index |
18 |
|
dental caries |
17 |
|
dmf index |
17 |
|
china |
16 |
|
periodontal disease |
16 |
|
dentistry |
15 |
|
female |
15 |
|
male |
15 |
|
case-control studies |
14 |
|
cross-sectional studies |
14 |
|
statistics, nonparametric |
14 |
|
chi-square distribution |
13 |
|
follow-up studies |
13 |
|
quality of life |
13 |
|
risk factors |
13 |
|
health status |
12 |
|
oral microbiome |
12 |
|
periodontal status |
12 |
|
aged, 80 and over |
11 |
|
chronic periodontitis |
11 |
|
microbiology |
11 |
|
nasopharyngeal neoplasms - radiotherapy |
11 |
|
prospective studies |
11 |
|
xerostomia |
11 |
|
hong kong |
10 |
|
nasopharyngeal carcinoma |
10 |
|
periodontal diseases |
10 |
|
adolescent |
9 |
|
age factors |
9 |
|
blood glucose - analysis |
9 |
|
china - ethnology |
9 |
|
dental plaque - microbiology |
9 |
|
mouth - microbiology |
9 |
|
survey |
9 |
|
analysis of variance |
8 |
|
carcinoma - radiotherapy |
8 |
|
chinese |
8 |
|
complications |
8 |
|
diabetes complications |
8 |
|
diabetes mellitus |
8 |
|
diabetes mellitus, type 2 - complications |
8 |
|
dose-response relationship, drug |
8 |
|
education |
8 |
|
health status indicators |
8 |
|
nasopharyngeal neoplasms - complications - radiotherapy |
8 |
|
saliva |
8 |
|
salivation - radiation effects |
8 |
|
smoking |
8 |
|
anaerobic bacteria |
7 |
|
cohort studies |
7 |
|
dental anxiety |
7 |
|
gram-negative aerobic rods and cocci - classification |
7 |
|
gram-negative facultatively anaerobic rods - classification |
7 |
|
hemoglobin a, glycosylated - analysis |
7 |
|
kidney transplantation |
7 |
|
patient satisfaction |
7 |
|
periodontal attachment loss - complications |
7 |
|
risk assessment |
7 |
|
sjögren's syndrome |
7 |
|
statistics as topic |
7 |
|
toll-like receptor 4 |
7 |
|
treatment outcome |
7 |
|
cell hypoxia |
6 |
|
children |
6 |
|
cross-over studies |
6 |
|
dental implants |
6 |
|
dna, bacterial - analysis |
6 |
|
double-blind method |
6 |
|
fnirs |
6 |
|
functional near-infrared spectroscopy |
6 |
|
gram-negative facultatively anaerobic rods - isolation & purification |
6 |
|
health status measures |
6 |
|
health surveys |
6 |
|
health-related quality of life |
6 |
|
intensity-modulated radiotherapy |
6 |
|
lymphocyte antigen 96 |
6 |
|
medical |
6 |
|
medical sciences |
6 |
|
muscarinic agonists - adverse effects - therapeutic use |
6 |
|
near-infrared |
6 |
|
oral hygiene index |
6 |
|
parotid sparing |
6 |
|
psychomotor skills training |
6 |
|
questionnaire |
6 |
|
questionnaires |
6 |
|
quinuclidines - adverse effects - therapeutic use |
6 |
|
radiotherapy dosage |
6 |
|
salivary flow |
6 |
|
salivary flow rate |
6 |
|
severity of illness index |
6 |
|
sex factors |
6 |
|
simulation |
6 |
|
sjogren's syndrome - complications - ethnology |
6 |
|
sjogren's syndrome - psychology - rehabilitation |
6 |
|
spectroscopy |
6 |
|
thiophenes - adverse effects - therapeutic use |
6 |
|
type 2 diabetes mellitus |
6 |
|
vascular endothelial growth factor a |
6 |
|
virtual reality |
6 |
|
xerostomia - drug therapy - ethnology - etiology |
6 |
|
xerostomia - etiology - rehabilitation |
6 |
|
alzheimer’s disease |
5 |
|
anti-bacterial agents - pharmacology |
5 |
|
antibiotics |
5 |
|
apical periodontitis |
5 |
|
bacteria, anaerobic - drug effects - isolation & purification |
5 |
|
bisphosphonate-related osteonecrosis of the jaws |
5 |
|
calcium chloride |
5 |
|
calcium hydroxide |
5 |
|
calcium hydroxide - pharmacology |
5 |
|
candida - classification |
5 |
|
candida albicans - enzymology - isolation & purification |
5 |
|
candidiasis - microbiology |
5 |
|
candidiasis, oral - classification |
5 |
|
caries |
5 |
|
child |
5 |
|
chronic disease |
5 |
|
cognitive dysfunctions |
5 |
|
colony count, microbial |
5 |
|
cranial irradiation - adverse effects |
5 |
|
curriculum |
5 |
|
cyclosporine - therapeutic use |
5 |
|
demeclocycline - pharmacology |
5 |
|
dental |
5 |
|
dental caries - classification |
5 |
|
dental equipment |
5 |
|
dental implant |
5 |
|
dental pulp cavity - microbiology |
5 |
|
diet |
5 |
|
disease-free survival |
5 |
|
drug combinations |
5 |
|
emotions |
5 |
|
endodontic treatment |
5 |
|
enteric rods |
5 |
|
enterobacteriaceae - classification |
5 |
|
functional neuroimaging |
5 |
|
genotype |
5 |
|
gingival overgrowth |
5 |
|
gingival overgrowth - chemically induced - classification |
5 |
|
gingival overgrowth - chemically induced - complications - microbiology |
5 |
|
gingivitis |
5 |
|
gram-negative bacteria - drug effects |
5 |
|
gram-positive bacteria - drug effects |
5 |
|
gram-positive rods - isolation & purification |
5 |
|
hemolysin proteins - biosynthesis |
5 |
|
hypertension - complications |
5 |
|
immunocompromised host |
5 |
|
immunosuppressive agents - adverse effects |
5 |
|
immunosuppressive agents - therapeutic use |
5 |
|
income |
5 |
|
lipopolysaccharide |
5 |
|
mouth diseases - classification |
5 |
|
nasopharyngeal neoplasms - mortality - radiotherapy |
5 |
|
nasopharyngeal neoplasms - pathology - radiotherapy - surgery |
5 |
|
neomycin - pharmacology |
5 |
|
neoplasm staging |
5 |
|
neuroinflammation |
5 |
|
neurosciences |
5 |
|
oral disease |
5 |
|
oral microbiology |
5 |
|
ovariectomy |
5 |
|
parotid gland - physiology - radiation effects |
5 |
|
parotid gland - radiation effects |
5 |
|
peptide hydrolases - biosynthesis |
5 |
|
periapical periodontitis - microbiology |
5 |
|
periodontal attachment loss - classification |
5 |
|
periodontal diseases - classification |
5 |
|
periodontal diseases - therapy |
5 |
|
periodontal pocket - pathology - therapy |
5 |
|
periodontics |
5 |
|
periodontitis - complications |
5 |
|
periodontitis - complications - microbiology |
5 |
|
periodontitis - therapy |
5 |
|
phylogeny |
5 |
|
pilot projects |
5 |
|
polymyxin b - pharmacology |
5 |
|
potassium chloride |
5 |
|
poverty |
5 |
|
pseudomonas - isolation & purification |
5 |
|
psychology, social |
5 |
|
quality of life - psychology |
5 |
|
radiation injuries - complications |
5 |
|
radiation injuries - etiology - prevention & control |
5 |
|
radiotherapy |
5 |
|
radiotherapy adverse effects |
5 |
|
radiotherapy, conformal - adverse effects |
5 |
|
radiotherapy, intensity-modulated |
5 |
|
randomized controlled clinical trial |
5 |
|
rat |
5 |
|
root canal irrigants - pharmacology |
5 |
|
root caries - classification |
5 |
|
saliva - secretion |
5 |
|
salivary glands - physiopathology - radiation effects |
5 |
|
smoking - adverse effects |
5 |
|
sodium bicarbonate |
5 |
|
sodium chloride |
5 |
|
stenotrophomonas maltophilia |
5 |
|
stenotrophomonas maltophilia - isolation & purification |
5 |
|
steroid |
5 |
|
survival rate |
5 |
|
synergistetes |
5 |
|
tacrolimus - therapeutic use |
5 |
|
tibetans |
5 |
|
tooth diseases - classification |
5 |
|
transplantation, homologous |
5 |
|
triamcinolone acetonide - pharmacology |
5 |
|
trismus - classification |
5 |
|
tyrothricin - pharmacology |
5 |
|
xerostomia - classification |
5 |
|
xerostomia - etiology |
5 |
|
xerostomia - etiology - prevention & control |
5 |
|
xerostomia - prevention & control |
5 |
|
yeasts |
5 |
|
zoledronic acid |
5 |
|
acinetobacter - classification |
4 |
|
actinobacillus actinomycetemcomitans - isolation & purification |
4 |
|
adult periodontitis |
4 |
|
bacteremia - epidemiology - microbiology |
4 |
|
bacteria - classification - growth & development |
4 |
|
bacteria - classification - isolation & purification |
4 |
|
bacterial genome |
4 |
|
bacterial typing techniques |
4 |
|
bacteriological techniques |
4 |
|
bacteroides - isolation & purification |
4 |
|
bibliometric |
4 |
|
biodiversity |
4 |
|
biopsy |
4 |
|
biostatistics |
4 |
|
candidiasis, oral - epidemiology - microbiology |
4 |
|
carcinoma - complications - radiotherapy |
4 |
|
cftr |
4 |
|
chronic periodontitis - metabolism - pathology |
4 |
|
citrobacter - classification |
4 |
|
clonality |
4 |
|
cluster of differentiation |
4 |
|
cystic fibrosis transmembrane conductance regulator - analysis - genetics - metabolism |
4 |
|
dental calculus - epidemiology - ethnology |
4 |
|
dental care - utilization |
4 |
|
dental caries - epidemiology - ethnology |
4 |
|
dental plaque |
4 |
|
dental plaque biofilm |
4 |
|
dental scaling |
4 |
|
dentures - adverse effects |
4 |
|
diagnosis |
4 |
|
dinoprostone - analysis - metabolism |
4 |
|
disease progression |
4 |
|
diversity |
4 |
|
dna sequencing |
4 |
|
drug resistance, bacterial |
4 |
|
ecology |
4 |
|
electrophoresis, gel, pulsed-field |
4 |
|
endocarditis - epidemiology - microbiology |
4 |
|
endothelial cells - metabolism - pathology |
4 |
|
enterobacter - classification |
4 |
|
epithelial cells - metabolism - pathology |
4 |
|
escherichia - classification |
4 |
|
escherichia coli |
4 |
|
etiology |
4 |
|
fibroblasts |
4 |
|
flavobacterium - classification |
4 |
|
fmri |
4 |
|
gene expression |
4 |
|
gingiva - metabolism - pathology |
4 |
|
gingiva - microbiology |
4 |
|
gingival crevice |
4 |
|
gingival crevicular fluid |
4 |
|
gingival crevicular fluid - immunology - metabolism |
4 |
|
gingival epithelium |
4 |
|
granulocyte elastase |
4 |
|
health services needs and demand - statistics & numerical data |
4 |
|
hyoid bone |
4 |
|
hypoxia-inducible factor 1-α subunit |
4 |
|
hypoxia-inducible factor 1α subunit |
4 |
|
illumina |
4 |
|
immunohistochemistry |
4 |
|
immunology and microbiology |
4 |
|
incidence |
4 |
|
infection |
4 |
|
insula of reil |
4 |
|
irradiation |
4 |
|
keratinocytes |
4 |
|
klebsiella - classification |
4 |
|
klebsiella pneumoniae - classification |
4 |
|
leukocyte elastase - analysis - metabolism |
4 |
|
limbic system |
4 |
|
lipopolysaccharides |
4 |
|
longitudinal studies |
4 |
|
meta-analysis |
4 |
|
metagenome |
4 |
|
metagenomics |
4 |
|
microbial ecology |
4 |
|
microscopy, fluorescence |
4 |
|
mlsa |
4 |
|
models |
4 |
|
models, statistical |
4 |
|
molecular biology |
4 |
|
mouth - microbiology - radiation effects |
4 |
|
mouth diseases - microbiology |
4 |
|
multilevel modeling |
4 |
|
neisseria - classification |
4 |
|
neural network models |
4 |
|
oral hygiene |
4 |
|
orthognathic surgery |
4 |
|
periodontal attachment loss - pathology - therapy |
4 |
|
periodontal diseases - epidemiology - ethnology |
4 |
|
periodontal pocket |
4 |
|
periodontitis - enzymology - immunology - microbiology |
4 |
|
periodontitis - microbiology |
4 |
|
periodontitis etiology |
4 |
|
periodontopathogen |
4 |
|
pge2 |
4 |
|
pharyngeal airway |
4 |
|
phenotype |
4 |
|
porphyromonas gingivalis - isolation & purification |
4 |
|
prevalence |
4 |
|
prevotella intermedia - isolation & purification |
4 |
|
pseudomonas - classification |
4 |
|
root-canal bacteria |
4 |
|
scleroderma |
4 |
|
sequencing |
4 |
|
smell |
4 |
|
soft tissue infection |
4 |
|
spirochete |
4 |
|
statistical |
4 |
|
systematic review |
4 |
|
taxonomy |
4 |
|
tibet - epidemiology |
4 |
|
tooth - microbiology |
4 |
|
tooth diseases - microbiology |
4 |
|
toothbrushing - utilization |
4 |
|
treponema |
4 |
|
treponema - isolation & purification |
4 |
|
tumor necrosis factor-alpha |
4 |
|
urban health - statistics & numerical data |
4 |
|
wound healing |
4 |
|
xerostomia - complications |
4 |
|
xerostomia - etiology - microbiology |
4 |
|
young adult |
4 |
|
actinobacillus actinomycetemcomitans |
3 |
|
actinobacillus actinomycetemcomitans - classification - genetics - isolation & purification |
3 |
|
actinobacillus infections |
3 |
|
adjunct care |
3 |
|
aging |
3 |
|
alveolar bone loss - complications - therapy |
3 |
|
animals |
3 |
|
anti-bacterial agents - administration & dosage |
3 |
|
antifungal agents - therapeutic use |
3 |
|
antimicrobial agents/inhibitors |
3 |
|
antimicrobials |
3 |
|
bacterial |
3 |
|
bacterial infection |
3 |
|
bacterial toxins - analysis |
3 |
|
bacterial virulence factor |
3 |
|
bgcs |
3 |
|
body mass index |
3 |
|
candida - isolation & purification |
3 |
|
candida albicans |
3 |
|
candidiasis, oral |
3 |
|
candidiasis, oral - complications - diagnosis - prevention & control |
3 |
|
candidiasis, oral - complications - drug therapy - microbiology - pathology |
3 |
|
carcinoma - microbiology - radiotherapy |
3 |
|
cell biology |
3 |
|
cells, cultured |
3 |
|
ceramic |
3 |
|
chronic periodontitis - complications |
3 |
|
clinical periodontal variables |
3 |
|
cranial irradiation |
3 |
|
cytolethal distending toxin gene |
3 |
|
dental caries - complications |
3 |
|
dental pellicle |
3 |
|
denture, complete, upper - adverse effects |
3 |
|
diabetes mellitus, type 2 - blood - complications - metabolism |
3 |
|
down syndrome |
3 |
|
down syndrome - complications |
3 |
|
epidemiology |
3 |
|
equine oral taxon (eot) |
3 |
|
erythritol |
3 |
|
essential hypertension |
3 |
|
exotoxins - analysis |
3 |
|
extraction |
3 |
|
furcation defects |
3 |
|
gingiva |
3 |
|
gingival crevicular fluid - chemistry |
3 |
|
gingival hemorrhage - etiology |
3 |
|
gram-negative anaerobic bacteria - isolation and purification |
3 |
|
gram-negative bacteria - growth and development |
3 |
|
haptic |
3 |
|
head and neck irradiation |
3 |
|
health behavior |
3 |
|
hiv infections - complications |
3 |
|
home care |
3 |
|
host-microbial interactions |
3 |
|
immunology |
3 |
|
impacted tooth |
3 |
|
inflammation |
3 |
|
interleukin-8 |
3 |
|
interleukin-8 - analysis |
3 |
|
journal impact factor |
3 |
|
l. reuteri |
3 |
|
lactobacillus - classification - isolation and purification |
3 |
|
lactobacillus acidophilus - isolation and purification |
3 |
|
lactobacillus reuteri |
3 |
|
leukocyte elastase - analysis |
3 |
|
leukotoxin gene |
3 |
|
lifestyle |
3 |
|
linear models |
3 |
|
lipopolysaccharide-binding protein |
3 |
|
local delivery |
3 |
|
mass spectrometry |
3 |
|
metagenomic sequencing |
3 |
|
microbial communities |
3 |
|
microorganism |
3 |
|
minocycline |
3 |
|
minocycline - administration & dosage |
3 |
|
molar |
3 |
|
molar - pathology |
3 |
|
molar, third - surgery |
3 |
|
mouth mucosa - microbiology |
3 |
|
mucositis |
3 |
|
mycology |
3 |
|
mycoses - drug therapy - microbiology - pathology |
3 |
|
nasopharyngeal neoplasms - microbiology - radiotherapy |
3 |
|
nonsurgical periodontal debridement |
3 |
|
non‐surgical periodontal therapy |
3 |
|
nucleic acids and periodontal disease |
3 |
|
obesity - complications |
3 |
|
oral health status |
3 |
|
oral hygiene - methods |
3 |
|
patient outcome assessment |
3 |
|
peri-implantitis |
3 |
|
periodontal attachment loss |
3 |
|
periodontal diseases - classification - etiology |
3 |
|
periodontal diseases - complications |
3 |
|
periodontal diseases - complications - diagnosis |
3 |
|
periodontal ligament - pathology - radiography |
3 |
|
periodontal organisms |
3 |
|
periodontal pocket - drug therapy - microbiology |
3 |
|
periodontal pocket - etiology |
3 |
|
periodontal pocket - microbiology |
3 |
|
periodontal pocket - therapy |
3 |
|
periodontal therapy |
3 |
|
periodontics and essential hypertension |
3 |
|
periodontics and taxonomy |
3 |
|
periodontitis - microbiology - therapy |
3 |
|
periodontitis - prevention & control - therapy |
3 |
|
periodontium-gingiva |
3 |
|
plaque |
3 |
|
polymorphisms |
3 |
|
probiotics |
3 |
|
protein |
3 |
|
protein signal peptide |
3 |
|
proteogenomic |
3 |
|
pyrosequencing |
3 |
|
root planing |
3 |
|
root surface debridement |
3 |
|
salivary proteins and peptides |
3 |
|
scleroderma, systemic - complications |
3 |
|
secondary metabolites |
3 |
|
serotype |
3 |
|
sjogren's syndrome - classification - complications - microbiology |
3 |
|
sjogren's syndrome - microbiology - physiopathology |
3 |
|
spirochaetes |
3 |
|
statistical model |
3 |
|
streptococcus mitis - isolation & purification |
3 |
|
stress |
3 |
|
subgingival plaque |
3 |
|
supportive periodontal care |
3 |
|
surface properties |
3 |
|
swine |
3 |
|
systemic |
3 |
|
systemic sclerosis |
3 |
|
third molar |
3 |
|
toll-like receptors |
3 |
|
tooth extraction - adverse effects |
3 |
|
tooth loss |
3 |
|
tooth loss - etiology |
3 |
|
tooth, impacted - surgery |
3 |
|
toothbrushing - instrumentation |
3 |
|
treatment response |
3 |
|
treponema denticola |
3 |
|
tumor necrosis factor-alpha - blood |
3 |
|
type-2 diabetes mellitus |
3 |
|
ump kinase |
3 |
|
16s |
2 |
|
acceptance |
2 |
|
acquired enamel pellicle |
2 |
|
actinomyces |
2 |
|
acute-phase proteins - analysis |
2 |
|
acute-phase proteins - analysis - immunology |
2 |
|
acute-phase proteins - pharmacology |
2 |
|
adenine |
2 |
|
aesthetic outcome |
2 |
|
affection |
2 |
|
age distribution |
2 |
|
aggressive periodontitis |
2 |
|
aggressive periodontitis - genetics - immunology |
2 |
|
alveolar bone loss |
2 |
|
alveolar bone loss - immunology - pathology |
2 |
|
alveolar bone loss - pathology |
2 |
|
amyloid-β |
2 |
|
analgesics |
2 |
|
anti-infective agents - pharmacology |
2 |
|
anti-infective agents, local - administration & dosage |
2 |
|
antigens, cd14 |
2 |
|
antigens, cd14 - analysis |
2 |
|
antigens, cd14 - analysis - drug effects |
2 |
|
antigens, cd14 - biosynthesis |
2 |
|
antigens, surface - analysis - drug effects |
2 |
|
asia - epidemiology |
2 |
|
aspartic endopeptidases - antagonists & inhibitors - metabolism - secretion |
2 |
|
bacterial -- congresses. |
2 |
|
bacterial etiology |
2 |
|
bacterial phylogeny |
2 |
|
bbb permeability |
2 |
|
behavior |
2 |
|
bibliometrics |
2 |
|
biofilms |
2 |
|
calcium phosphates |
2 |
|
calcium signaling - drug effects |
2 |
|
candida albicans - cytology - enzymology - ultrastructure |
2 |
|
cardiac myocyte |
2 |
|
cardiotonic agents - administration and dosage - therapeutic use |
2 |
|
carrier proteins - analysis |
2 |
|
carrier proteins - analysis - drug effects - pharmacology |
2 |
|
carrier proteins - analysis - immunology |
2 |
|
caseins |
2 |
|
cd14 |
2 |
|
cd14 antigens |
2 |
|
cells |
2 |
|
chlorhexidine |
2 |
|
chlorhexidine - administration & dosage |
2 |
|
chronic periodontitis - genetics |
2 |
|
chronic periodontitis - genetics - immunology |
2 |
|
chronic periodontitis - immunology - pathology |
2 |
|
chronic periodontitis - prevention and control - psychology - therapy |
2 |
|
clinical study |
2 |
|
clinical trial |
2 |
|
collagen |
2 |
|
complement c5 |
2 |
|
complement c5 - genetics |
2 |
|
connective tissue - immunology - pathology |
2 |
|
connective tissue - pathology |
2 |
|
connectivity |
2 |
|
ctla-4 antigen |
2 |
|
cytokines - analysis - drug effects |
2 |
|
cytoplasm - ultrastructure |
2 |
|
cytosine |
2 |
|
dendritic cells - pathology |
2 |
|
dental amalgam |
2 |
|
dental anxiety - prevention & control |
2 |
|
dental calculus - ethnology |
2 |
|
dental care - manpower |
2 |
|
dental care for chronically ill |
2 |
|
dental caries - ethnology |
2 |
|
dental fear |
2 |
|
dental health surveys - statistics & numerical data |
2 |
|
dental plaque - complications - therapy |
2 |
|
dental prophylaxis |
2 |
|
dental prophylaxis - methods |
2 |
|
dental treatment |
2 |
|
dentine sensitivity |
2 |
|
dento-skeletal class ii |
2 |
|
dento-skeletal class iii |
2 |
|
diabetes |
2 |
|
diagnostic imaging |
2 |
|
disclosure |
2 |
|
down syndrome. |
2 |
|
down-regulation |
2 |
|
drug administration routes |
2 |
|
drug delivery systems |
2 |
|
drug implants |
2 |
|
endodontics |
2 |
|
endothelial cells - pathology |
2 |
|
endothelium, vascular - pathology |
2 |
|
epidemiology and periodontal disease |
2 |
|
epithelial attachment - immunology - pathology |
2 |
|
epithelial cells - pathology |
2 |
|
epithelium - immunology - pathology |
2 |
|
epithelium - pathology |
2 |
|
escherichia coli - immunology |
2 |
|
extracellular space - drug effects - enzymology |
2 |
|
extracellular space - immunology |
2 |
|
factors associated |
2 |
|
fcγ receptor |
2 |
|
fibroblast |
2 |
|
fibroblasts - cytology - drug effects |
2 |
|
fibroblasts - immunology |
2 |
|
functional magnetic resonance imaging |
2 |
|
gels |
2 |
|
gene expression regulation, bacterial |
2 |
|
gene frequency - genetics |
2 |
|
genetic variation - genetics |
2 |
|
genetics |
2 |
|
gingiva - cytology - drug effects |
2 |
|
gingiva - cytology - immunology |
2 |
|
gingiva - immunology - metabolism |
2 |
|
gingiva - pathology |
2 |
|
gingival hemorrhage - pathology - therapy |
2 |
|
gingival interleukin-6 |
2 |
|
gingival tissues |
2 |
|
gingivitis. |
2 |
|
gingivitis/pathogenesis |
2 |
|
glass ionomer cements |
2 |
|
guanine |
2 |
|
guided periodontal tissue regeneration |
2 |
|
haplotypes |
2 |
|
human gingival fibroblasts |
2 |
|
hydrogels |
2 |
|
hypoxia |
2 |
|
igg. |
2 |
|
il-6 |
2 |
|
image processing, computer-assisted |
2 |
|
immunity, innate - immunology |
2 |
|
immunologic factors - genetics |
2 |
|
impact factor |
2 |
|
in vivo |
2 |
|
infection and periodontics |
2 |
|
infectious diseases |
2 |
|
information science |
2 |
|
initial periodontal therapy |
2 |
|
insula |
2 |
|
intensity |
2 |
|
interleukin-10 |
2 |
|
interleukin-10 - analysis - immunology |
2 |
|
interleukin-1beta - analysis - immunology |
2 |
|
interleukin-1β |
2 |
|
interleukin-6 - analysis |
2 |
|
introns - genetics |
2 |
|
ischemic preconditioning, myocardial - methods |
2 |
|
library science |
2 |
|
limbic lobe |
2 |
|
linkage disequilibrium - genetics |
2 |
|
lipopolysaccharide receptors |
2 |
|
lipopolysaccharides - administration and dosage - therapeutic use |
2 |
|
lipopolysaccharides - analysis |
2 |
|
lipopolysaccharides - immunology |
2 |
|
lipopolysaccharides - pharmacology |
2 |
|
literature |
2 |
|
literature-based discovery |
2 |
|
locus coeruleus |
2 |
|
macrophages - immunology - pathology |
2 |
|
macrophages - pathology |
2 |
|
mandibular setback |
2 |
|
membrane glycoproteins |
2 |
|
membrane glycoproteins - analysis |
2 |
|
membrane glycoproteins - analysis - drug effects - pharmacology |
2 |
|
membrane glycoproteins - analysis - immunology |
2 |
|
microbial phylogeny |
2 |
|
microbiology -- congresses. |
2 |
|
molars |
2 |
|
mouth - microbiology. |
2 |
|
mouthwashes - therapeutic use |
2 |
|
multilocus sequence analysis |
2 |
|
muramidase - metabolism - pharmacology |
2 |
|
myocardial reperfusion injury |
2 |
|
neurodegeneration |
2 |
|
neuroimaging |
2 |
|
neuroimaging journals |
2 |
|
nlr proteins |
2 |
|
nucleic acids |
2 |
|
oceania - epidemiology |
2 |
|
operational taxonomic unit |
2 |
|
oral health patient-centered measure |
2 |
|
oral hygiene - utilization |
2 |
|
oral microbiota |
2 |
|
oral surgery |
2 |
|
oral surgical procedures - psychology |
2 |
|
oral treponeme |
2 |
|
pathogenicity |
2 |
|
patient compliance - psychology |
2 |
|
periodontal attachment loss - immunology - pathology |
2 |
|
periodontal attachment loss - pathology |
2 |
|
periodontal disease and quality of life |
2 |
|
periodontal diseases - immunology - pathology |
2 |
|
periodontal organisms -- congresses. |
2 |
|
periodontal pocket - immunology - metabolism |
2 |
|
periodontal pocket - immunology - pathology |
2 |
|
periodontal pocket - pathology |
2 |
|
periodontal pockets |
2 |
|
periodontal splints |
2 |
|
periodontics and quality of life |
2 |
|
periodontitis - complications - drug therapy - therapy |
2 |
|
periodontitis - epidemiology |
2 |
|
periodontitis - genetics - immunology |
2 |
|
periodontitis - immunology - metabolism |
2 |
|
periodontitis - pathology |
2 |
|
periodontitis - pathology - therapy |
2 |
|
periodontitis/pathogenesis |
2 |
|
periodontium - immunology |
2 |
|
phylogenetic analysis |
2 |
|
phylogroup |
2 |
|
polymorphism |
2 |
|
polymorphism, genetic |
2 |
|
polymorphism, single nucleotide - genetics |
2 |
|
porphyromonas gingivalis |
2 |
|
pre-operative information |
2 |
|
preoperative care |
2 |
|
preventive dentistry |
2 |
|
prognosis |
2 |
|
proportional hazards models |
2 |
|
proteomics |
2 |
|
psychosocial aspects |
2 |
|
publication |
2 |
|
publications |
2 |
|
quality |
2 |
|
radiograph |
2 |
|
readability |
2 |
|
receptor |
2 |
|
receptors |
2 |
|
receptors, cell surface - analysis - drug effects |
2 |
|
receptors, igg - genetics |
2 |
|
recombinant proteins |
2 |
|
research evaluation |
2 |
|
reverse transcriptase polymerase chain reaction |
2 |
|
reverse transcription-polymerase chain reaction |
2 |
|
ribosomal |
2 |
|
rna |
2 |
|
rural health - statistics and numerical data |
2 |
|
self-reported questionnaire |
2 |
|
sex distribution |
2 |
|
single nucleotide |
2 |
|
single-nucleotide |
2 |
|
spirochete -- congresses. |
2 |
|
supportive periodontal therapy |
2 |
|
systemic disease |
2 |
|
systemic inflammation |
2 |
|
taste |
2 |
|
third molars. |
2 |
|
tibet - ethnology |
2 |
|
toll-like receptor 2 |
2 |
|
toll-like receptor 2 - analysis |
2 |
|
toll-like receptor 4 - analysis |
2 |
|
toothpastes - therapeutic use |
2 |
|
trait anxiety |
2 |
|
virulence |
2 |
|
adaptation, psychological |
1 |
|
adults |
1 |
|
alpha subunit |
1 |
|
anions - metabolism |
1 |
|
antigens, bacterial - analysis - genetics - metabolism |
1 |
|
antigens, bacterial - chemistry |
1 |
|
antigens, bacterial - metabolism |
1 |
|
antigens, surface - analysis - genetics |
1 |
|
antigens, surface - chemistry |
1 |
|
anxiety |
1 |
|
attachment |
1 |
|
bacteria, anaerobic - isolation and purification |
1 |
|
bacterial adhesion |
1 |
|
bacterial outer membrane proteins - chemistry |
1 |
|
bacterial outer membrane proteins - isolation & purification - toxicity |
1 |
|
bacterial proteins |
1 |
|
c1r |
1 |
|
candidiasis |
1 |
|
cardiovascular diseases |
1 |
|
cations - metabolism |
1 |
|
cell membrane - metabolism |
1 |
|
cell movement |
1 |
|
cell signaling |
1 |
|
cho cells |
1 |
|
chymotrypsin - toxicity |
1 |
|
cloning, molecular |
1 |
|
collagen type iii |
1 |
|
conserved sequence |
1 |
|
coping |
1 |
|
cox-2 |
1 |
|
cpitn |
1 |
|
cranial irradiation - adverse effects - statistics & numerical data |
1 |
|
cyclic neutropenia |
1 |
|
delivery of health care, integrated |
1 |
|
dental anxiety - diagnosis |
1 |
|
dental anxiety - epidemiology |
1 |
|
dental restoration, permanent - statistics & numerical data |
1 |
|
dorsal root ganglia |
1 |
|
ehlers-danlos syndrome |
1 |
|
ehlers–danlos syndrome |
1 |
|
electrophoresis, polyacrylamide gel |
1 |
|
epithelial cells |
1 |
|
facet design |
1 |
|
genes, bacterial |
1 |
|
genetic disorders |
1 |
|
geriatric dentistry |
1 |
|
gingival recession - psychology |
1 |
|
health services for the aged |
1 |
|
hereditary gingival fibromatosis |
1 |
|
hypophosphatasia |
1 |
|
hypoxia-inducible factor-1 |
1 |
|
interprofessional education |
1 |
|
ion channels - chemistry |
1 |
|
irradiation therapy |
1 |
|
manifest anxiety scale |
1 |
|
marital status - statistics & numerical data |
1 |
|
mastication - physiology |
1 |
|
mitogenactivated protein kinase |
1 |
|
molar, third - microbiology |
1 |
|
nursing homes |
1 |
|
patient-centered measure |
1 |
|
pericoronal pouch |
1 |
|
pericoronitis |
1 |
|
pericoronitis - complications - microbiology |
1 |
|
pericoronitis index |
1 |
|
periodontal attachment loss - epidemiology |
1 |
|
periodontal attachment loss - etiology |
1 |
|
periodontal attachment loss - etiology - psychology |
1 |
|
periodontal attachment loss - psychology |
1 |
|
periodontal ligament - cytology - drug effects |
1 |
|
porins - analysis - chemistry - genetics |
1 |
|
porins - chemistry - metabolism |
1 |
|
primary health care |
1 |
|
prostaglandin e2 |
1 |
|
proteinase |
1 |
|
psychological tests |
1 |
|
psychology |
1 |
|
regression analysis |
1 |
|
reproducibility of results |
1 |
|
satellite glial cells |
1 |
|
serine endopeptidases - toxicity |
1 |
|
south-asian countries |
1 |
|
stress, psychological - complications |
1 |
|
tlr4 |
1 |
|
tobacco |
1 |
|
toll-like receptor-4 |
1 |
|
tooth, impacted - complications - microbiology |
1 |
|
trait |
1 |
|
translations |
1 |
|
treponema - chemistry - genetics - ultrastructure |
1 |
|
treponema - chemistry - ultrastructure |
1 |
|
treponema - enzymology - immunology - pathogenicity |
1 |
|
treponema - genetics - immunology - physiology |
1 |
|
treponema - pathogenicity |
1 |
|
treponema denticola, epithelial proliferation, apoptosis |
1 |
|
validity |
1 |
|
world health organization |
1 |
|
制备 (preparation) |
1 |
|
抗病毒 (anti-viral) |
1 |
|
抗肿瘤 (anti-tumor) |
1 |
|
抗菌 (antibacterial) |
1 |
|
纳米银 (silver nanoparticles) |
1 |
